Skip to main content
. 2022 Aug 5;29(1):85–93. doi: 10.1016/j.cmi.2022.07.006

Fig. 2.

Fig. 2

Cumulative risk of symptomatic and asymptomatic COVID-19 by treatmentgroup, EPICOS randomized trial. (a) Symptomatic COVID-19, (b) Asymptomatic COVID-19, (c) Any COVID-19. Abbreviations: HCQ, hydroxychloroquine; FTC, emtricitabine; TDF, tenofovir disoproxil fumarate.